表紙
市場調查報告書

全球搭配診斷市場

Companion Diagnostics

出版商 Global Industry Analysts, Inc. 商品編碼 222510
出版日期 內容資訊 英文 248 Pages
商品交期: 最快1-2個工作天內
價格
全球搭配診斷市場 Companion Diagnostics
出版日期: 2020年09月01日內容資訊: 英文 248 Pages
簡介

本報告提供全球搭配診斷市場相關調查,市場趨勢與各市場區隔概要,各地區趨勢,及市場進入主要企業的簡介與競爭趨勢相關資訊。

第1章 簡介,調查方法,產品定義

第2章 產業概要

第3章 市場趨勢與課題

  • 個人化醫療的重要性是市場主要推動因素
  • 搭配診斷領導個人化醫療之道
  • 個人化醫療的研究開發的降低成本可實現搭配診斷
  • 搭配診斷造成的標靶治療的改良 其他

第4章 產品概要

  • 個人化醫療的診斷
  • 遺傳基因檢驗
  • 搭配診斷
  • 搭配診斷:如何起作用
  • 搭配診斷所使用的技術
  • 搭配診斷的生物標記
  • 搭配診斷的應用概要
  • 藥物開發過程的搭配診斷所扮演的角色
  • 臨床實驗的搭配診斷
  • 治療領域的搭配診斷
  • 腫瘤學的搭配診斷
  • 發炎性疾病的搭配診斷
  • 感染疾病的搭配診斷
  • 藥物代謝的搭配診斷
  • 相關利益者的見解 其他

第5章 競爭環境

  • 世界的參與企業
  • 產品認證/上市
  • 近幾年的產業活動

第6章 全球市場預測

第7章 各地區市場預測

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 其他各國

第8章 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6736

Global Companion Diagnostics Market to Reach $9.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Companion Diagnostics estimated at US$3.4 Billion in the year 2020, is projected to reach a revised size of US$9.2 Billion by 2027, growing at aCAGR of 15.1% over the period 2020-2027. Assay kits & Reagents, one of the segments analyzed in the report, is projected to record 14.3% CAGR and reach US$6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Software & Services segment is readjusted to a revised 16.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1 Billion, While China is Forecast to Grow at 14.6% CAGR

The Companion Diagnostics market in the U.S. is estimated at US$1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 14.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.5% and 13% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 11.1% CAGR.We bring years of research experience to this 18th edition of our report. The 248-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Molecular
  • Agilent Technologies, Inc.
  • bioMerieux SA
  • Cepheid
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Foundation Medicine Inc.
  • Laboratory Corporation of America® Holdings
  • Leica Biosystems Nussloch GmbH
  • Merck & Co. Inc.
  • Myriad Genetics Inc.
  • NeoGenomics Laboratories, Inc.
  • QIAGEN N.V.
  • Quest Diagnostics Inc.
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • Companion Diagnostics: An Introductory Prelude
    • Quashing the One-Size-Fits-All Approach, CDx Wield Great Promise for Streamlined Drug Discovery & Development
    • Broader Scope and Applications Rev Up Growth Opportunities
    • Healthy Growth Projected over the Next Few Years
    • Developed Regions: Key Revenue Contributors
    • Market Witnesses Fast Paced Growth in Developing Regions
    • Northbound Trajectory in R&D Spending Creates Conducive Environment
    • Prevailing Economic Scenario Favors Funding Pattern
    • Global Competitor Market Shares
    • Companion Diagnostics Competitor Market Share Scenario Worldwide (in %): 2018 &
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Significance of Personalized Medicine Remains a Major Market Driver
    • Emphasis on Improving Targeted Therapies with CDx Tests Steers Momentum
    • Herceptin Lays the Road for Companion Diagnostics
    • Oncology - Dominant Therapy Area for CDx
    • Rising Incidence of Cancer Propels the Need for CDx Tests
    • Technology Advancements to Widen CDx Use Case
    • PCR: Dominant Technology Type for CDx Testing
    • Next-Generation Sequencing (NGS) Gains Widespread Traction in CDx Testing
    • Significant Role of Biomarkers in Companion Diagnostics
    • Critical Healthcare Needs of Aging Population Underpin CDx Sales
    • Regulatory Scenario Favors CDx Market
    • Resolving Prevailing Challenges: Critical for Future Growth of CDx Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: Companion Diagnostics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020
    • TABLE 2: Companion Diagnostics Market Share Shift across Key Geographies Worldwide: 2020 VS
    • TABLE 3: Assay kits & Reagents (Product & Service) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 4: Assay kits & Reagents (Product & Service) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS
    • TABLE 5: Software & Services (Product & Service) Potential Growth Markets Worldwide in US$ Million: 2020 to
    • TABLE 6: Software & Services (Product & Service) Market Sales Breakdown by Region/Country in Percentage: 2020 VS
    • TABLE 7: Polymerase Chain Reaction (PCR) (Technology) Geographic Market Spread Worldwide in US$ Million: 2020 to
    • TABLE 8: Polymerase Chain Reaction (PCR) (Technology) Market Share Distribution in Percentage by Region/Country: 2020 VS
    • TABLE 9: Immunohistochemistry (IHC) (Technology) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to
    • TABLE 10: Immunohistochemistry (IHC) (Technology) Market Share Breakdown by Region/Country: 2020 VS
    • TABLE 11: In Situ Hybridization (ISH) (Technology) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 12: In Situ Hybridization (ISH) (Technology) Market Share Distribution in Percentage by Region/Country: 2020 VS
    • TABLE 13: Next-Generation Sequencing (NGS) (Technology) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to
    • TABLE 14: Next-Generation Sequencing (NGS) (Technology) Market Percentage Share Distribution by Region/Country: 2020 VS
    • TABLE 15: Other Technologies (Technology) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to
    • TABLE 16: Other Technologies (Technology) Market Share Distribution in Percentage by Region/Country: 2020 VS
    • TABLE 17: Oncology (Indication) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 18: Oncology (Indication) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS
    • TABLE 19: Neurology (Indication) Potential Growth Markets Worldwide in US$ Million: 2020 to
    • TABLE 20: Neurology (Indication) Market Sales Breakdown by Region/Country in Percentage: 2020 VS
    • TABLE 21: Other Indications (Indication) Geographic Market Spread Worldwide in US$ Million: 2020 to
    • TABLE 22: Other Indications (Indication) Market Share Distribution in Percentage by Region/Country: 2020 VS
    • TABLE 23: Pharmaceutical & Biopharmaceutical Companies (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020
    • TABLE 24: Pharmaceutical & Biopharmaceutical Companies (End-Use) Distribution of Global Sales by Region/Country: 2020 VS
    • TABLE 25: Reference Laboratories (End-Use) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through
    • TABLE 26: Reference Laboratories (End-Use) Global Market Share Distribution by Region/Country for 2020 and
    • TABLE 27: CROs (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2020
    • TABLE 28: CROs (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2020 VS
    • TABLE 29: Other End-Uses (End-Use) Worldwide Sales in US$ Million by Region/Country: 2020
    • TABLE 30: Other End-Uses (End-Use) Market Share Shift across Key Geographies: 2020 VS

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Companion Diagnostics Market Share (in %) by Company: 2018 &
    • Market Analytics
    • TABLE 31: United States Companion Diagnostics Market Estimates and Projections in US$ Million by Product & Service: 2020 to
    • TABLE 32: United States Companion Diagnostics Market Share Breakdown by Product & Service: 2020 VS
    • TABLE 33: Companion Diagnostics Market in US$ Million in the United States by Technology: 2020
    • TABLE 34: United States Companion Diagnostics Market Share Breakdown by Technology: 2020 VS
    • TABLE 35: United States Companion Diagnostics Market Estimates and Projections in US$ Million by Indication: 2020 to
    • TABLE 36: United States Companion Diagnostics Market Share Breakdown by Indication: 2020 VS
    • TABLE 37: United States Companion Diagnostics Latent Demand Forecasts in US$ Million by End-Use: 2020 to
    • TABLE 38: Companion Diagnostics Market Share Breakdown in the United States by End-Use: 2020 VS
  • CANADA
    • TABLE 39: Canadian Companion Diagnostics Market Estimates and Forecasts in US$ Million by Product & Service: 2020 to
    • TABLE 40: Companion Diagnostics Market in Canada: Percentage Share Breakdown of Sales by Product & Service for 2020 and
    • TABLE 41: Companion Diagnostics Market Analysis in Canada in US$ Million by Technology: 2020
    • TABLE 42: Canadian Companion Diagnostics Market Share Breakdown by Technology: 2020 VS
    • TABLE 43: Canadian Companion Diagnostics Market Estimates and Forecasts in US$ Million by Indication: 2020 to
    • TABLE 44: Companion Diagnostics Market in Canada: Percentage Share Breakdown of Sales by Indication for 2020 and
    • TABLE 45: Canadian Companion Diagnostics Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
    • TABLE 46: Canadian Companion Diagnostics Market Share Analysis by End-Use: 2020 VS
  • JAPAN
    • TABLE 47: Japanese Market for Companion Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product & Service for the Period 2020
    • TABLE 48: Japanese Companion Diagnostics Market Share Analysis by Product & Service: 2020 VS
    • TABLE 49: Japanese Medium & Long-Term Outlook for Companion Diagnostics Market in US$ Million by Technology: 2020
    • TABLE 50: Japanese Companion Diagnostics Market Percentage Share Distribution by Technology: 2020 VS
    • TABLE 51: Japanese Market for Companion Diagnostics: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2020
    • TABLE 52: Japanese Companion Diagnostics Market Share Analysis by Indication: 2020 VS
    • TABLE 53: Japanese Demand Estimates and Forecasts for Companion Diagnostics in US$ Million by End-Use: 2020 to
    • TABLE 54: Companion Diagnostics Market Share Shift in Japan by End-Use: 2020 VS
  • CHINA
    • TABLE 55: Chinese Companion Diagnostics Market Growth Prospects in US$ Million by Product & Service for the Period 2020
    • TABLE 56: Chinese Companion Diagnostics Market by Product & Service: Percentage Breakdown of Sales for 2020 and
    • TABLE 57: Companion Diagnostics Market Estimates and Forecasts in China in US$ Million by Technology: 2020
    • TABLE 58: Companion Diagnostics Market in China: Percentage Share Analysis by Technology for 2020 and
    • TABLE 59: Chinese Companion Diagnostics Market Growth Prospects in US$ Million by Indication for the Period 2020
    • TABLE 60: Chinese Companion Diagnostics Market by Indication: Percentage Breakdown of Sales for 2020 and
    • TABLE 61: Chinese Demand for Companion Diagnostics in US$ Million by End-Use: 2020 to
    • TABLE 62: Chinese Companion Diagnostics Market Share Breakdown by End-Use: 2020 VS
  • EUROPE
    • Market Facts & Figures
    • European Companion Diagnostics Market: Competitor Market Share Scenario (in %) for 2018 &
    • Market Analytics
    • TABLE 63: European Companion Diagnostics Market Demand Scenario in US$ Million by Region/Country: 2018
    • TABLE 64: European Companion Diagnostics Market Share Shift by Region/Country: 2020 VS
    • TABLE 65: European Companion Diagnostics Market Estimates and Forecasts in US$ Million by Product & Service: 2020
    • TABLE 66: European Companion Diagnostics Market Share Breakdown by Product & Service: 2020 VS
    • TABLE 67: European Companion Diagnostics Market Assessment in US$ Million by Technology: 2020
    • TABLE 68: Companion Diagnostics Market in Europe: Percentage Breakdown of Sales by Technology for 2020 and
    • TABLE 69: European Companion Diagnostics Market Estimates and Forecasts in US$ Million by Indication: 2020
    • TABLE 70: European Companion Diagnostics Market Share Breakdown by Indication: 2020 VS
    • TABLE 71: European Companion Diagnostics Addressable Market Opportunity in US$ Million by End-Use: 2020
    • TABLE 72: European Companion Diagnostics Market Share Analysis by End-Use: 2020 VS
  • FRANCE
    • TABLE 73: Companion Diagnostics Market in France by Product & Service: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 74: French Companion Diagnostics Market Share Analysis by Product & Service: 2020 VS
    • TABLE 75: French Companion Diagnostics Market Estimates and Projections in US$ Million by Technology: 2020
    • TABLE 76: French Companion Diagnostics Market Share Breakdown by Technology: 2020 VS
    • TABLE 77: Companion Diagnostics Market in France by Indication: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 78: French Companion Diagnostics Market Share Analysis by Indication: 2020 VS
    • TABLE 79: Companion Diagnostics Quantitative Demand Analysis in France in US$ Million by End-Use: 2020
    • TABLE 80: French Companion Diagnostics Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and
  • GERMANY
    • TABLE 81: Companion Diagnostics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product & Service for the Period 2020
    • TABLE 82: German Companion Diagnostics Market Share Breakdown by Product & Service: 2020 VS
    • TABLE 83: German Companion Diagnostics Latent Demand Forecasts in US$ Million by Technology: 2020
    • TABLE 84: German Companion Diagnostics Market Share Breakdown by Technology: 2020 VS
    • TABLE 85: Companion Diagnostics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2020
    • TABLE 86: German Companion Diagnostics Market Share Breakdown by Indication: 2020 VS
    • TABLE 87: Companion Diagnostics Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020
    • TABLE 88: Companion Diagnostics Market Share Distribution in Germany by End-Use: 2020 VS
  • ITALY
    • TABLE 89: Italian Companion Diagnostics Market Growth Prospects in US$ Million by Product & Service for the Period 2020
    • TABLE 90: Italian Companion Diagnostics Market by Product & Service: Percentage Breakdown of Sales for 2020 and
    • TABLE 91: Companion Diagnostics Market Estimates and Forecasts in Italy in US$ Million by Technology: 2020
    • TABLE 92: Companion Diagnostics Market in Italy: Percentage Share Analysis by Technology for 2020 and
    • TABLE 93: Italian Companion Diagnostics Market Growth Prospects in US$ Million by Indication for the Period 2020
    • TABLE 94: Italian Companion Diagnostics Market by Indication: Percentage Breakdown of Sales for 2020 and
    • TABLE 95: Italian Demand for Companion Diagnostics in US$ Million by End-Use: 2020 to
    • TABLE 96: Italian Companion Diagnostics Market Share Breakdown by End-Use: 2020 VS
  • UNITED KINGDOM
    • TABLE 97: United Kingdom Market for Companion Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product & Service for the Period 2020
    • TABLE 98: United Kingdom Companion Diagnostics Market Share Analysis by Product & Service: 2020 VS
    • TABLE 99: United Kingdom Medium & Long-Term Outlook for Companion Diagnostics Market in US$ Million by Technology: 2020
    • TABLE 100: United Kingdom Companion Diagnostics Market Percentage Share Distribution by Technology: 2020 VS
    • TABLE 101: United Kingdom Market for Companion Diagnostics: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2020
    • TABLE 102: United Kingdom Companion Diagnostics Market Share Analysis by Indication: 2020 VS
    • TABLE 103: United Kingdom Demand Estimates and Forecasts for Companion Diagnostics in US$ Million by End-Use: 2020 to
    • TABLE 104: Companion Diagnostics Market Share Shift in the United Kingdom by End-Use: 2020 VS
  • REST OF EUROPE
    • TABLE 105: Rest of Europe Companion Diagnostics Market Estimates and Forecasts in US$ Million by Product & Service: 2020
    • TABLE 106: Rest of Europe Companion Diagnostics Market Share Breakdown by Product & Service: 2020 VS
    • TABLE 107: Rest of Europe Companion Diagnostics Market Assessment in US$ Million by Technology: 2020
    • TABLE 108: Companion Diagnostics Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2020 and
    • TABLE 109: Rest of Europe Companion Diagnostics Market Estimates and Forecasts in US$ Million by Indication: 2020
    • TABLE 110: Rest of Europe Companion Diagnostics Market Share Breakdown by Indication: 2020 VS
    • TABLE 111: Rest of Europe Companion Diagnostics Addressable Market Opportunity in US$ Million by End-Use: 2020
    • TABLE 112: Rest of Europe Companion Diagnostics Market Share Analysis by End-Use: 2020 VS
  • ASIA-PACIFIC
    • TABLE 113: Companion Diagnostics Market in Asia-Pacific by Product & Service: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 114: Asia-Pacific Companion Diagnostics Market Share Analysis by Product & Service: 2020 VS
    • TABLE 115: Asia-Pacific Companion Diagnostics Market Estimates and Projections in US$ Million by Technology: 2020
    • TABLE 116: Asia-Pacific Companion Diagnostics Historic Market Analysis in US$ Million by Technology: 2020 VS
    • TABLE 117: Companion Diagnostics Market in Asia-Pacific by Indication: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 118: Asia-Pacific Companion Diagnostics Market Share Analysis by Indication: 2020 VS
    • TABLE 119: Companion Diagnostics Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020
    • TABLE 120: Asia-Pacific Companion Diagnostics Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and
  • REST OF WORLD
    • TABLE 121: Rest of World Companion Diagnostics Market Estimates and Forecasts in US$ Million by Product & Service: 2020 to
    • TABLE 122: Companion Diagnostics Market in Rest of World: Percentage Share Breakdown of Sales by Product & Service for 2020 and
    • TABLE 123: Companion Diagnostics Market Analysis in Rest of World in US$ Million by Technology: 2020
    • TABLE 124: Rest of World Companion Diagnostics Market Share Breakdown by Technology: 2020 VS
    • TABLE 125: Rest of World Companion Diagnostics Market Estimates and Forecasts in US$ Million by Indication: 2020 to
    • TABLE 126: Companion Diagnostics Market in Rest of World: Percentage Share Breakdown of Sales by Indication for 2020 and
    • TABLE 127: Rest of World Companion Diagnostics Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
    • TABLE 128: Rest of World Companion Diagnostics Market Share Analysis by End-Use: 2020 VS

IV. COMPETITION

  • Total Companies Profiled: 80